Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical Infectious Diseases"
DOI: 10.1093/cid/cix519
Abstract: Background MenB-4C is a recently licensed meningococcal serogroup B vaccine. For vaccine licensure, short-term efficacy was inferred from serum bactericidal antibody (SBA) titers against 3 antigen-specific indicator strains, which are not necessarily representative of US…
read more here.
Keywords:
meningococcal serogroup;
campus;
university;
vaccine ... See more keywords